BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment

Winter, Georg E., Mayer, Andreas, Buckley, Dennis L., Erb, Michael A., Roderick, Justine E., Vittori, Sarah, Reyes, Jaime M., di Iulio, Julia +15 more·2017·Molecular Cell
DOI 10.1016/j.molcel.2017.06.004

Cited by (469)

Items 401–469 of 469

  1. Transcriptional pause release at enhancers mediates cell identity
    Thomas L. Ekstrom, Steven A. Johnsen · 2025 · NAR Cancer
  2. Decoding Bromodomain and Extra-Terminal Domain Protein-Mediated Epigenetic Mechanisms in Human Uterine Fibroids
    Qiwei Yang, Somayeh Vafaei, Ali Falahati, Azad Khosh, Mervat Mostafa Omran, Tao Bai, María Victoria Bariani, Mohamed K. Ali, Thomas Boyer, Ayman A. Al-Hendy · 2025 · International Journal of Molecular Sciences
  3. BRD3 PROTAC degrader targets H3K18ac to alleviate retinal microglia-driven uveitis
    Zhi Zhang, Tianlong Lan, Y.-C. Liu, Hui Yang, Nan Shu, Ruonan Li, Wanqian Li, Qian Zhou, Peizeng Yang, Yu Rao et al. · 2025 · iScience
  4. Discovery of an orally bioavailable pyridone-based BRD4 inhibitor with potent antitumor efficacy in colorectal cancer
    Zhangyun Fang, Shuai Zhan, Churu Mao, Ningjing Zhang, Xiaofeng Zhao, Yun Huang, Wanjing Ding, Zhongjun Ma · 2026 · European Journal of Medicinal Chemistry
  5. Proteasome Cap Targeting Chimeras for Ubiquitination‐Independent Targeted Protein Degradation
    Chen Song, Qi Liu, Tingjian Wang, Yan Y. Song, Logan H. Sigua, Paul M.C. Park, Scott B. Ficarro, Sunwoo Liv Lee, S. Picaud, P. Filippakopoulos et al. · 2026 · Angewandte Chemie
  6. PROTACs in cancer therapy: targeted degradation of GPX4, PARP and epigenetic regulators
    Sunny Periyasamy, Thyla Jarrett, Joe Truong, Rachid Skouta · 2026 · Journal of Enzyme Inhibition and Medicinal Chemistry
  7. Photo‐click Proteolysis‐Targeting Chimeras Enable Intracellular Generation of PROTACs for Precise Dual Protein Degradation
    Jing Pang, Shihong Li, Yuhui Zhang, Qingyu Jia, Ya‐Qiu Long · 2026 · Angewandte Chemie International Edition
  8. Real-Time NanoBRET Target Engagement Reveals Permeability-Activity Relationships in BET-Targeting Degraders
    Alexander Engstrom, James D. Vasta, Matthew B. Robers, R. Scott Lokey · 2026 · Journal of Medicinal Chemistry
  9. Evaluation of Benzo[ cd ]indol‐2(1 H )‐ones as Downstream Hedgehog Pathway Inhibitors
    Ioannis A. Tsakoumagkos, Quentin T. L. Pasquer, Christian‐Louis Guillod, Charlotte Rossion, Meropi Bagka, Sonya Torche, Tomoyo Sakata, James Chen, Sascha Hoogendoorn · 2025 · ChemistryOpen
  10. The extra-terminal domain drives the role of BET proteins in transcription
    Iwona Pasionek, John B. Ridenour, Agnieszka Machowska, Magdalena Donczew, Michael T Kinter, Kevin A Boyd, Rafał Donczew · 2026 · Nucleic Acids Research
  11. Structural and Biophysical Principles of Degrader Ternary Complexes
    David Zollman, Alessio Ciulli · 2020 · Royal Society of Chemistry eBooks
  12. Bromodomain Protein, BRD4, Contributes to the Regulation of Alternative Splicing
    Sheetal Uppal, Qingrong Chen, Daoud M. Meerzaman, Anne Gégonne, Dinah S. Singer · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  13. Trivalent PROTACs Enhance Protein Degradation Through Cooperativity and Avidity
    Satomi Imaide, Kristin M. Riching, Vesna Vetma, Claire Whitworth, Scott J. Hughes, Nicole B. Trainor, Sarah D. Mahan, Nancy Murphy, Kwok-Ho Chan, Andrea Testa et al. · 2020 · ChemRxiv
  14. Tuning the open-close equilibrium of Cereblon with small molecules influences protein degradation
    Suzanne O’Connor, Zoe J. Rutter, Angus D. Cowan, Markus Zeeb, Florian P. C. Binder, Yuting Cao, Sohini Chakraborti, Stefan Djukic, Leonhard Geist, Elizabeth K. J. Hogg et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  15. Identification of clofibric acid as a SYVN1 ligand for PROTAC development
    Warren, Julia, MD, PhD, Anandarao Munakala, Keith D. Zientek, Kilsun Kim, Phillip A. Wilmarth, Ashok P. Reddy, Bingbing X. Li, Xiangshu Xiao · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  16. Overcoming the Protective Effect of the Bone Marrow Microenvironment by Dual FLT3 and BET Inhibition in FLT3-ITD Acute Myeloid Leukemia
    Lauren Lee · 2019
  17. BETter together: exploiting BRD4-functions in transcription to inform rational combinations
    Fabio Savarese, Norbert Kraut · 2018 · Oncoscience
  18. BET mechanisms in cancer
    Elizabeth Henderson, P. Filippakopoulos · 2020 · Elsevier eBooks
  19. The 2nd Alpine Winter Conference on Medicinal and Synthetic Chemistry
    Alessio Ciulli, Lawrence G. Hamann, Wolfgang Jahnke, Amit S.S. Kalgutkar, Thomas Magauer, Tobias Ritter, Vicky Steadman, S. D. Williams, Georg E. Winter, Klemens Hoegenauer et al. · 2021 · ChemMedChem
  20. Faculty Opinions recommendation of RNAs interact with BRD4 to promote enhanced chromatin engagement and transcription activation.
    Yamini Dalal · 2018 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  21. Faculty Opinions recommendation of BRD4 prevents the accumulation of R-loops and protects against transcription-replication collision events and DNA damage.
    Cheng‐Ming Chiang · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  22. Faculty Opinions recommendation of RNAs interact with BRD4 to promote enhanced chromatin engagement and transcription activation.
    Tatiana G. Kutateladze, Catherine A. Musselman · 2018 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  23. Faculty Opinions recommendation of The dTAG system for immediate and target-specific protein degradation.
    Songon An · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  24. Neue Einblicke in die Genregulation mittels funktioneller Multiomik
    Annkatrin Bressin, Andreas Mayer · 2022 · BIOspektrum
  25. Acute resistance to BET inhibitors remodels compensatory transcriptional programs via p300 co-activation
    Viral Shah, George Giotopoulos, Hikari Osaki, Markus Meyerhöfer, Eshwar Meduri, Benedict Schubert, Haiyang Yun, Sarah J. Horton, Shuchi Agrawal Singh, Patricia S. Haehnel et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  26. A Structural and Biophysical Perspective of Degrader Activity Through Ternary Complex Formation
    Morgan S. Gadd, Marine C. Aublette · 2022 · Wiley eBooks
  27. Recurrent nuclear protein of the testis carcinoma of the submandibular gland treated with multimodality therapy: A case report and review of the literature
    Kaixin Guo, Chenggong Zeng, Hongyu Jiang, Wenhao Luo, Zijun Zhen, Yujie Liang · 2023 · Pediatric Hematology Oncology Journal
  28. CRISPR-ChIP delineates a Menin-dependent oncogenic DOT1L complex in MLL- leukaemia
    Omer Gilan, Charles C. Bell, Laure Talarmain, Daniel Neville, Kathy Knezevic, Daniel Ferguson, Marion Boudes, Yih-Chih Chan, Chen Davidovich, Enid Y.N. Lam et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  29. Data from Chromatin Looping Shapes KLF5-Dependent Transcriptional Programs in Human Epithelial Cancers
    Yanli Liu, Bingqian Guo, Estrella Aguilera-Jimenez, Vivian S. Chu, Jin Zhou, Zhong Wu, Joshua M. Francis, Xiaojun Yang, Peter S. Choi, Swneke Donovan Bailey et al. · 2023
  30. Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics
    Ophir Shalem, Yevgeniy V. Serebrenik, D.R. Mani, Timothé Maujean, George M. Burslem · 2023 · Research Square
  31. The ESCRT protein CHMP5 promotes T cell leukemia by controlling BRD4-p300-dependent transcription
    Katharine Umphred-Wilson, Shashikala Ratnayake, Qianzi Tang, Rui Wang, Ballachanda N. Devaiah, Lan Zhou, Qingrong Chen, Daoud M. Meerzaman, Dinah S. Singer, Stanley Adoro · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  32. The Integrator complex prevents premature neuronal differentiation through global control of transcription elongation
    Hedda B. Somsen, Kristel N. Eigenhuis, Anne L. Kuijpers-Korporaal, Mariana Pelicano de Almeida, Roberto Montoro Ferrer, K. Peter Kats, Mike R. Dekker, Thuur Zuidweg, Zakia Azmani, Mirjam C. G. N. van den Hout et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  33. Rational Design of CDK12/13 and BRD4 Molecular Glue Degraders
    Zhe Zhuang, Woong Sub Byun, Zuzanna Kozicka, Katherine A. Donovan, Brendan G. Dwyer, Abby M. Thornhill, Hannah M. Jones, Zixuan Jiang, Xijun Zhu, Eric S. Fischer et al. · 2025 · Angewandte Chemie
  34. Degraders of proteins in epigenetic regulation
    Tong‐Fei Li, Jun Hu, Liu‐Gen Li, Cunqing Kong, Ning Han, Fan Leng, Zhijie Xu, Yuanliang Yan · 2025 · Elsevier eBooks
  35. Single-Assay Characterization of Ternary Complex Assembly and Activity in Targeted Protein Degradation
    Corey H. Yu, Vi Dougherty, Dongwen Lv, Pirouz Ebadi, Shikha Dubey, Digant Nayak, Anindita Nayak, Daohong Zhou, Shaun K. Olsen, Dmitri N. Ivanov · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  36. BRD2 bridges TFIID and histone acetylation to promote transcriptional initiation
    Bin Zheng, Ruxuan Qiu, Sarah R. Gold, Marta Iwanaszko, Yuki Aoi, Benjamin Charles Howard, Madhurima Das, Ali Shilatifard · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  37. Gαq-Stimulated Gene Expression Is Insensitive to Bromo Extra Terminal Domain Inhibitors in HEK 293 Cells
    Ashika Jain, Viviane Pagé, Dominic Devost, Darlaine Pétrin, Terence E. Hébert, Jason C. Tanny · 2025 · International Journal of Molecular Sciences
  38. Association of MiR-29b/BRD4 with Airway Dysbiosis in Chronic Obstructive Pulmonary Disease after Smoking Cessation
    Siyi Zhou, Yu-xin Zeng, Tao Yu, Jianmiao Wang · 2025 · Current Medical Science
  39. Structure–activity relationships in a series of dihydrouracil–JQ1 conjugates: discovery of highly potent BRD4 degraders
    Oleh Shyshlyk, V. O. Stadnichenko, Oleksandr Diachenko, Iryna Chernysh, Anna Beshtynarska, Diana O. Alieksieieva, Diana Khotinets, Oleksii Oleksiak, Dmytro S. Lesyk, Yelyzaveta Yeremenko et al. · 2026 · RSC Medicinal Chemistry
  40. Systematic molecular glue drug discovery with a high-throughput effector protein remodeling platform
    Jia Lu, Kate Stuart, Rebecca Teague, Chloe Tarry, Robert Yan, Tabitha Morgan, Elizabeth Nock, Darcie S Mulhearn, Matt Jones, Michael H. Knaggs et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  41. PROTACS- targeted protein degradation as a path to precision cancer therapeutics
    Hannah R Gatley, Paul B. Fisher, Swadesh Kumar Das · 2025 · Advances in cancer research
  42. Additional file 1 of BRD4 is involved in viral exacerbation of chronic obstructive pulmonary disease
    Duan, Yifei, Zhou, Siyi, Wang, Jianmiao · 2023 · Figshare
  43. Additional file 5 of GeneWalk identifies relevant gene functions for a biological context using network representation learning
    Robert Ietswaart, Benjamin M. Gyori, John A. Bachman, Peter Karl Sorger, L. Stirling Churchman · 2021 · Figshare
  44. Additional file 1 of GeneWalk identifies relevant gene functions for a biological context using network representation learning
    Robert Ietswaart, Benjamin M. Gyori, John A. Bachman, Peter Karl Sorger, L. Stirling Churchman · 2021 · Figshare
  45. Recent advance in the targeted protein degradation technology for overcoming acute leukemia
    Xin Jin, Zhonghua Shi, Zhuo Liang, Jia Chen, Chenxi Wang, Yongxin Lou, Xiaoran Cao, Lei Zhu, Yihuan Zhao, Changkuo Zhao et al. · 2026 · European Journal of Medicinal Chemistry Reports
  46. Profiling Extrachromosomal Circular DNA (ecDNA) in Cancer via Next-Generation Sequencing: A New Frontier in Tumor Evolution and Therapy Resistance
    Sareh Bakhshandeh Bavarsad, Narges Mohammadgholiha, Mohammad Javad Hayati, Javad Yaghmoorian Khojini, Fatemeh Sadat Haghighi, Amirhossein Azimi, Seyed Mohammad Gheibi Hayat · 2026 · Anti-Cancer Agents in Medicinal Chemistry
  47. Leucémies aigüs lymphoblastiques T (LAL-T) et dérégulation épigénétique
    Aurore Touzart · 2018
  48. Contrôle de l'expression génique par la RNP 7SK
    Cécilia Studniarek · 2019 · theses.fr (ABES)
  49. FragLite mapping to identify the BRD4 recruitment site of P-TEFb
    Ian Hope, Richard Heath, Arnaud Baslé, Mathew P. Martin, Michael J. Waring, Jane Endicott, Martin E. M. Noble, Natalie J. Tatum · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  50. Photo‐click Proteolysis‐Targeting Chimeras Enable Intracellular Generation of PROTACs for Precise Dual Protein Degradation
    Jing Pang, Shihong Li, Yuhui Zhang, Qingyu Jia, Ya‐Qiu Long · 2026 · Angewandte Chemie
  51. Correction of the molecular phenotype of X-linked Dystonia-Parkinsonism reveals a non-canonical function of BRD4
    Simona Capponi, Sandra Ehret, Zeynep Camgöz, Fabian Gather, Christine A. Vaine, Ezgi Ozyerli‐Goknar, Marie Follo, D. Cristopher Bragg, Tanja Vogel, H. T. Marc Timmers · 2026 · Nature Communications
  52. Protein Age Bias in Target Degradation by PROTACs
    Bingbing X. Li, Xiangshu Xiao · 2026 · ACS Chemical Biology
  53. Identification of RET PROTAC with excellent degradation efficiency against medullary thyroid carcinoma
    Jaewon Song, Sugene Lim, Eunhye Jeon, Chanil Kim, Seung Min Park, Jong Bae Park, Taebo Sim · 2026 · European Journal of Medicinal Chemistry
  54. Rapid Transcription Dynamics Confers Cytarabine Resistance in Acute Myeloid Leukemia
    Goichi Tatsumi, Rajni Kumari, Yutaro Suzuki, Shuting Li, Russell Scharf, Samuel J. Taylor, Sriram Sundaravel, Amit K. Verma, Justin C. Wheat, Ulrich Steidl · 2026 · Blood Cancer Discovery
  55. Identification of Clofibric Acid as a Synoviolin (SYVN1) Ligand for Proteolysis-Targeting Chimera (PROTAC) Development
    Warren, Julia, MD, PhD, Anandarao Munakala, Keith D. Zientek, Kilsun Kim, Phillip A. Wilmarth, Ashok P. Reddy, Bingbing X. Li, Xiangshu Xiao · 2026 · ACS Medicinal Chemistry Letters
  56. A real-time FRET ubiquitin transfer assay for quantitative characterization of ternary complexes in targeted protein degradation
    Corey H. Yu, Vi Dougherty, Dongwen Lv, Pirouz Ebadi, Shikha Dubey, Digant Nayak, Anindita Nayak, Daohong Zhou, Shaun K. Olsen, Dmitri N. Ivanov · 2026 · Cell Reports Methods
  57. Design of Synthesizable PROTACs through Synthesis Constrained Generative Model and Reinforcement Learning
    Mingyuan Xu, Chaoming Huang, Li Pang, Qirui Deng, Hao Zhang, Anjie Qiao, Zhiwen Luo, Zhen Wang, Chang‐Yu Hsieh, Z Zhang et al. · 2026 · JACS Au
  58. Implant-associated infection induces systemic immune reprogramming
    Wanqiong Yuan, Jie Huang, Huan Wang, Yundi Zhang, Hao Zhou, Chenggui Zhang, Tiantong Sun, Chunli Song · 2026 · Medical Review
  59. Transcription elongation by RNA polymerase II: from regulatory complexity to disease
    Didem Naz Dioken, Elisabeth Altendorfer, Andreas Mayer · 2026 · Trends in Cell Biology
  60. Haploinsufficiency of brd4 causes adult-onset cardiac arrhythmia and cardiomyopathy in zebrafish
    Yonghe Ding, Yujuan Niu, Wenjing Dong, Taiwei Ma, Chengwen Gao, Peng Yang, Wenyu Ma, Shuai Liu, Xinying Sun, ShiHao Wang et al. · 2026 · Research Square
  61. Epigenetic rewiring of immunological memory in cancer: heterogeneity, mechanisms, and therapeutic vulnerabilities
    Wenna Liu, Xiaole Pan, Yujia Zhao, Zhimei Li, Dan Wu, Ying Liang · 2026 · Frontiers in Immunology
  62. NONO mitigates transcription-replication conflicts during replication stress by restraining BRD4-dependent transcription elongation
    Wenchi Wu, Chengyan Ding, Jiameng Ma, Chao Li, Feng Long, Zhiyuan Feng, Cuiling Wang, Kaiping Hou, Jiawei Liu, Haoyuan Luo et al. · 2026 · Cell Reports
  63. BindingDB Entry 50015286: Discovery of Dual TAF1-ATR Inhibitors and Ligand-Induced Structural Changes of the TAF1 Tandem Bromodomain.
    BindingDB · 2023 · UC San Diego
  64. BindingDB Entry 50021782: Expanding the ligand spaces for E3 ligases for the design of protein degraders.
    BindingDB · 2025 · UC San Diego
  65. BindingDB Entry 50019285: Selective degradation of cellular BRD3 and BRD4-L promoted by PROTAC molecules in six cancer cell lines.
    BindingDB · 2024 · UC San Diego
  66. BindingDB Entry 50017778: Adjusted degradation of BRD4 S and BRD4 L based on fine structural modifications of the pyrrolopyridone scaffold.
    BindingDB · 2023 · UC San Diego
  67. BindingDB Entry 50016017: Development of an N-Terminal BRD4 Bromodomain-Targeted Degrader.
    BindingDB · 2023 · UC San Diego
  68. BindingDB Entry 50008588: Discovery of QCA570 as an Exceptionally Potent and Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of the Bromodomain and Extra-Terminal (BET) Proteins Capable of Inducing Complete and Durable Tumor Regression.
    BindingDB · 2021 · UC San Diego
  69. Targeted protein degradation in cancer: strategies for undruggable targets and progress towards clinical translation
    Jinxin Tang, Zehao Cheng, Tian Xie, Yan Zhuang, Hongkun Hu, Chenbei Li, Hua Wang, Chengyao Feng, Chao Tu · 2026 · Biomarker Research